DouglasSDenhamDO

Family Medicine • San Antonio, TX

Medical Director at Clinical Trials of Texas

Join to view full profile

Dr. Denham is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Denham's full profile

Already have an account?

Office
7400 Crestway Rd
San Antonio, TX 78239
Phone+1 210-569-9800

Fax+1 210-646-5606

Education & Training

University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineResidency, Family Medicine, 1989 - 1992
Texas College of Osteopathic MedicineClass of 1989
William & MaryNo Degree, Radiation Biology, 1981 - 1983
Hampden-Sydney CollegeB.S., Biology, 1977 - 1981

Certifications & Licensure

TX State License 1990 - 2025

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification athenaClinicals EHR, athenahealth, Inc, 2013
Phi Gamma Delta Hampden-Sydney College

Clinical Trials

Evaluate Safety and Effectiveness of MBX-102 in Type 2 Diabetes Patients With Poor Glycemic Control on Metformin Start of enrollment: 2008 Dec 01
Terminated
Phase 2
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus Start of enrollment: 2010 Jun 18
Completed
Phase 3
Clinical Trial for Evaluation of Vermillion's Blood Test to Predict the Probability of Peripheral Artery Disease Start of enrollment: 2011 Mar 01
Completed
Physiological and Biomechanical Data Collection Study in Epilepsy Subjects Start of enrollment: 2011 Nov 01
Completed
ECG Vector Determination Start of enrollment: 2011 Nov 01
Completed
Safety and Efficacy of Allogeneic Cells for the Treatment of Intermittent Claudication(IC) Start of enrollment: 2012 Nov 05
Completed
Phase 2
A Comparison of Two Treatment Strategies in Older Participants With Type 2 Diabetes Mellitus (T2DM) Start of enrollment: 2014 Feb 01
Terminated
Phase 4
Dasotraline SEP360-105 Pediatric PK/PD Study Start of enrollment: 2014 Jul 01
Completed
Phase 1
Safety and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) in the Treatment of Vulvovaginal Candidiasis (VVC) Start of enrollment: 2016 Nov 01
Completed
Phase 2
A Study to Test Whether Different Doses of BI 456906 Are Effective in Treating Adults With Type 2 Diabetes. Start of enrollment: 2020 Apr 30
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

Evaluation of Accuracy and Safety of the 365-Day Implantable Eversense Continuous Glucose Monitoring System: The ENHANCE Study.
Timothy S Bailey, David R Liljenquist, Douglas S Denham, Ronald L Brazg, Sorin Ioacara
Diabetes Technology & Therapeutics. 2025-01-27
Immunogenicity, efficacy, and safety of biosimilar insulin glargine (Gan & Lee glargine) compared with originator insulin glargine (Lantus®) in patients with type 2 di...
Elena A Christofides, Orlando Puente, Paul Norwood, Douglas Denham, Hiralal Maheshwari
Diabetes, Obesity & Metabolism. 2024-06-01
Publisher Correction: Glucagon receptor antagonist volagidemab in type 1 diabetes: a 12-week, randomized, double-blind, phase 2 trial.
Jeremy Pettus, Schafer C Boeder, Mark P Christiansen, Douglas S Denham, Timothy S Bailey
Nature Medicine. 2023-11-01

Press Mentions

San Antonio Researchers Conducting Trial for Potential COVID-19 Nasal Spray VaccinationMay 6th, 2021
Clinical Trials of Texas Conducts Clinical Trial of Implantable Device for Type 1 DiabetesSeptember 15th, 2019
San Antonio’s Clinical Trials of Texas Enrolls Patients for a Pneumonia Vaccine Clinical TrialJuly 16th, 2019